Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
0.9176
+0.0598 (6.97%)
At close: Apr 4, 2025, 4:00 PM
0.9004
-0.0172 (-1.88%)
After-hours: Apr 4, 2025, 7:51 PM EDT

Artelo Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2021 2016 - 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Aug '21 2016 - 2020
Net Income
-9.83-9.29-10.08-12.11-7.44
Upgrade
Loss (Gain) From Sale of Investments
-0.28-0.64-0.21-0.020
Upgrade
Stock-Based Compensation
0.821.022.462.81.53
Upgrade
Other Operating Activities
0.030.040.040.030.01
Upgrade
Change in Accounts Payable
0.480.270.021.5-0
Upgrade
Change in Other Net Operating Assets
0.430.39-0.24-0.21-0.24
Upgrade
Operating Cash Flow
-8.35-8.21-8.01-8-6.14
Upgrade
Investment in Securities
7.773.512.96-30.1-3.44
Upgrade
Investing Cash Flow
7.773.512.96-30.1-3.44
Upgrade
Short-Term Debt Issued
----0
Upgrade
Total Debt Issued
----0
Upgrade
Short-Term Debt Repaid
-----0.01
Upgrade
Total Debt Repaid
----0-0.01
Upgrade
Net Debt Issued (Repaid)
----0-0.01
Upgrade
Issuance of Common Stock
0.110.57-54.7914.12
Upgrade
Financing Cash Flow
0.110.57-54.7814.11
Upgrade
Foreign Exchange Rate Adjustments
-0.010.06-0.22-0.08-0.05
Upgrade
Net Cash Flow
-0.48-4.07-5.2716.64.49
Upgrade
Free Cash Flow
-8.35-8.21-8.01-8-6.14
Upgrade
Free Cash Flow Per Share
-2.59-2.77-2.83-3.59-4.93
Upgrade
Levered Free Cash Flow
-4.7-4.64-4.31--3.18
Upgrade
Unlevered Free Cash Flow
-4.7-4.64-4.3--3.18
Upgrade
Change in Net Working Capital
-0.8-0.550.33-0.06
Upgrade
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q